Skip to main content

High Levels of Glucose, Triglycerides Linked to Psychiatric Disorders

Medically reviewed by Carmen Pope, BPharm. Last updated on April 3, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, April 2, 2024 -- High levels of glucose and triglycerides are associated with future risk for depression, anxiety, and stress-related disorders, according to a study published online April 2 in JAMA Network Open.

Charilaos Chourpiliadis, M.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a population-based cohort study with longitudinal data collection involving 211,200 participants from the Apolipoprotein-Related Mortality Risk cohort who underwent occupational health screening to examine whether biomarkers of carbohydrate, lipid, and apolipoprotein metabolism are associated with the risk for depression, anxiety, and stress-related disorders.

The researchers found that 16,256 individuals were diagnosed with depression, anxiety, or stress-related disorders during a mean follow-up of 21.0 years. High levels of glucose and triglycerides were associated with an increased subsequent risk for all tested psychiatric disorders (hazard ratios, 1.30 and 1.15, respectively), while a reduced risk was seen in association with high levels of high-density lipoprotein (hazard ratio, 0.88). Similar results were seen for male and female participants and for all tested disorders. During the 20 years preceding diagnosis, patients with depression, anxiety, or stress-related disorders had higher levels of glucose, triglycerides, and total cholesterol; during the 10 years preceding diagnosis, higher levels of apolipoprotein A-I and apolipoprotein B were seen compared with controls.

"These results add further evidence of the association between cardiometabolic health and psychiatric disorders and potentially advocate for a closer follow-up of individuals with metabolic dysregulations for prevention and early diagnosis of psychiatric disorders," the authors write.

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Teens May Experience Delays in Bipolar Progression After Major Depressive Disorder

FRIDAY, May 31, 2024 -- Adolescents may experience delayed bipolar disorder (BD) progression after major depressive disorder (MDD) diagnosis, according to a study published online...

Teen Smartphone Use Positively Tied to Mood

THURSDAY, May 30, 2024 -- Adolescent smartphone use is positively associated with mood, according to a study published online May 29 in PLOS ONE. Matt Minich, Ph.D., and...

Some Healthy Teens Are Given Cannabidiol for Health Reasons

THURSDAY, May 30, 2024 -- About 3 percent of healthy adolescents are given commercial cannabidiol (CBD) for health reasons, according to a study published online May 7 in Cannabis...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.